Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion (Q40494312)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion |
scientific article |
Statements
1 reference
Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion (English)
1 reference
George Wilding
1 reference
Douglas G McNeel
1 reference
Jens Eickhoff
1 reference
Fred T Lee
1 reference
David M King
1 reference
Dona Alberti
1 reference
James P Thomas
1 reference
Andreas Friedl
1 reference
Jill Kolesar
1 reference
Rebecca Marnocha
1 reference
Jennifer Volkman
1 reference
Jianliang Zhang
1 reference
Luz Hammershaimb
1 reference
James A Zwiebel
1 reference
1 November 2005
1 reference
1 reference
Identifiers
1 reference